Hong Kong
· Delayed Price · Currency is HKD Venus Medtech (Hangzhou) Statistics
Total Valuation
HKG:2500 has a market cap or net worth of HKD 1.12 billion. The enterprise value is 1.19 billion.
| Market Cap | 1.12B |
| Enterprise Value | 1.19B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2500 has 441.01 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 441.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.55% |
| Owned by Institutions (%) | 16.75% |
| Float | 292.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.24 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.56 |
| EV / Sales | 2.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.22 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.96 |
Financial Efficiency
Return on equity (ROE) is -27.97% and return on invested capital (ROIC) is -7.22%.
| Return on Equity (ROE) | -27.97% |
| Return on Assets (ROA) | -5.96% |
| Return on Invested Capital (ROIC) | -7.22% |
| Return on Capital Employed (ROCE) | -12.66% |
| Revenue Per Employee | 725,105 |
| Profits Per Employee | -1.10M |
| Employee Count | 691 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.74% in the last 52 weeks. The beta is 0.86, so HKG:2500's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -57.74% |
| 50-Day Moving Average | 5.04 |
| 200-Day Moving Average | 7.27 |
| Relative Strength Index (RSI) | 64.93 |
| Average Volume (20 Days) | 755,475 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2500 had revenue of HKD 501.05 million and -760.15 million in losses. Loss per share was -1.74.
| Revenue | 501.05M |
| Gross Profit | 391.35M |
| Operating Income | -389.08M |
| Pretax Income | -788.25M |
| Net Income | -760.15M |
| EBITDA | -299.98M |
| EBIT | -389.08M |
| Loss Per Share | -1.74 |
Balance Sheet
The company has 325.32 million in cash and 392.77 million in debt, giving a net cash position of -67.45 million or -0.15 per share.
| Cash & Cash Equivalents | 325.32M |
| Total Debt | 392.77M |
| Net Cash | -67.45M |
| Net Cash Per Share | -0.15 |
| Equity (Book Value) | 2.35B |
| Book Value Per Share | 5.34 |
| Working Capital | 469.01M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.11%, with operating and profit margins of -77.65% and -151.71%.
| Gross Margin | 78.11% |
| Operating Margin | -77.65% |
| Pretax Margin | -157.32% |
| Profit Margin | -151.71% |
| EBITDA Margin | -59.87% |
| EBIT Margin | -77.65% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2500 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -67.86% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |